The Trump administration has backed away from an opioid ban affecting kratom products after lobbying from the industry, according to The New York Times.
The Times reports that health officials will allow some levels of a powerful substance to remain in products marketed as natural, a narrower step than an outright ban.
That shift is the event here. It leaves those products on the market with at least some permitted level of the substance still intact, rather than removing it altogether.
The Times also says the change could help a Republican donor who is facing wrongful-death lawsuits. Those lawsuits are allegations, not findings.
With only the Times summary available, the exact substance levels and the full terms of the policy change are not laid out there. But the direction is: after lobbying, the administration pulled back from a ban and chose to permit some amount of the substance to remain in products sold as natural.
Marcus Azzopardi 
Sophia Borg 
Alex de Valletta